Clinical trial

A Study of HS-10380 in Chinese Participants

NCT05480592

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-08-01

PhasePHASE1

Study timeline

Study start (actual)2022-08-01Date precision: day

Registry last updated2023-03-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

HS-10380DRUG

PlaceboDRUG

Sponsors & collaborators

Jiangsu Hansoh Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05480592 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.